Classified by application
All Products
Signaling Pathways
- Angiogenesis/Protein Tyrosine Kinase
- Apoptosis Pathway
- Cell Cycle/DNA Damage
- Epigenetics
-
GPCR/G Protein
- Melatonin Receptor
- Urotensin Receptor
- Neurotensin Receptor
- Motilin Receptor
- Glucose Transporter
- Adenylate Cyclase
- Cholecystokinin Receptor
- TGR5
- Bradykinin Receptor
- Oxytocin Receptor
- Somatostatin Receptor
- Guanylate Cyclase
- Melanocortin Receptor
- Imidazoline Receptor
- Neuropeptide Receptor
- PAR
- CRFR
- Sigma Receptor
- S1P Receptor
- GHSR
- PKA
- OX Receptor
- Adenosine Receptor
- Glucagon Receptor
- Prostaglandin Receptor
- NK Receptor
- GnRH Receptor
- Leukotriene Receptor
- Glucocorticoid Receptor
- mAChR
- P2 Receptor
- GPR
- CGRP Receptor
- CXCR
- Histamine Receptor
- CaSR
- Ras/Rho
- Vasopressin Receptor
- Smoothened/Smo
- Opioid Receptor
- mGluR
- Cannabinoid Receptor
- Dopamine Receptor
- Angiotensin Receptor
- Adrenergic Receptor
- SGLT
- Endothelin Receptor
- CCR
- 5 HT Receptor/Serotonin Receptor
- Hormone Pathay
- Ion Channel/Membrane Transporter
- Jak/Stat Pathway
- MAPK Pathway
- Microbiology/Virology
-
Neuro Signaling Pathway
- Imidazoline Receptor
- Monoamine Oxidase
- COMT
- Amyloid β
- NK Receptor
- Beta secretase
- AChE
- SSRI
- CaMK
- P glycoprotein
- Opioid Receptor
- Dopamine Receptor
- Adrenergic Receptor
- mGluR
- Histamine Receptor
- Gamma secretase
- Dopamine Transporter
- 5 HT Receptor/Serotonin Receptor
- FAAH
- P2 Receptor
- nAChR
- CGRP Receptor
- COX
- GABA Receptor
- mAChR
- NFκB
- PI3K/Akt/mTOR
-
Protease/Metabolic Enzyme
- 11β HSD
- COMT
- Carboxypeptidase
- ACC
- Xanthine Oxidase
- Mitochondrial Metabolism
- Pyruvate Kinase
- SCD
- ALDH
- Serine Protease
- Neprilysin
- CETP
- FTase
- MLR
- MAGL
- Carbonic Anhydrase
- E1 E2 E3 Enzyme
- Elastase
- Glucokinase
- ROR
- NOX
- PAI1
- Aldose Reductase
- Tyrosinase
- FAS
- DGAT
- Lipoxygenase
- Nampt
- IDO
- IDH
- MMP
- Cathepsin
- Phosphatase
- Thrombin
- FXR
- RAR/RXR
- HMGCR
- FAAH
- Gamma secretase
- RAAS/ACE
- Caspase
- HIV Protease
- Aminopeptidase
- HCV Protease
- HSP
- Tryptophan Hydroxylase/TPH
- Factor Xa
- DPP
- Procollagen C Proteinase
- Integrase
- Phosphodiesterase/PDE
- Phospholipase
- LXR
- Proteasome
- Cytochrome P450
- TGF beta/Smad
- Wnt/Stem Cell
- Others Pathway
Research Areas
- Metabolic Disease
- Neurological Disease
- Endocrinology
- Diabetes
- Cardiovascular Disease
- Immunology
- Allergy
- Inflammation
- Infection
- Cancer
Nature products
Antibodies
Peptides
Catalysts
Impurities
Intermediate
- Amino acid
- Ammonia Series
- Nucleoside Series
- Azaindazole
- Pyridazine Series
- Quinazoline
- Pyrimidine Series
- Pyrazole Series
- Quinoline Series
- Boric acid
- Pyrrole Series
- Thiophene Series
- Saccharide
- Azaindole
- Indole Series
- Piperidine Series
- Indazole Series
- Heterocyclic Series
- Pyridine Series
- Benzene Series
Raw Materials
BTK
Chemical Structure | Cat. No. | Product Name | CAS No. |
---|
![]() |
BCP38296 | Olmutinib dihydrochloride New | 1842366-97-5 |
Olmutinib is an orally available, mutant-selective third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) that is being developed for treatment of advanced and metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC).
|
![]() |
BCP37603 | Orelabrutinib New | 1655504-04-3 |
Orelabrutinib is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor, being developed by InnoCare Pharma, for the treatment of chronic lymphocytic leukaemia.
|
![]() |
BCP36887 | Remibrutinib New | 1787294-07-8 |
Remibrutinib, also known as LOU064, is a Bruton's tyrosine kinase inhibitor.
|
![]() |
BCP30305 | Btk inhibitor 1 R enantiomer hydrochloride New | 1553977-42-6 |
Btk inhibitor 1R enantiomer Hcl is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.
|
![]() |
BCP30763 | QL47 New | 1469988-75-7 |
QL47 is a potent, selective and irreversible BTK kinase inhibitor with IC50 of 7 nM.
|
![]() |
BCP30306 | BMX-IN-1 New | 1431525-23-3 |
BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.
|
![]() |
BCP30138 | PCI-29732 New | 330786-25-9 |
PCI-29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
|
![]() |
BCP30082 | (R)-Zanubrutinib New | 1691249-44-1 |
(R)-Zanubrutinib is the R enantiomer of Zanubrutinib. Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor.
|
![]() |
BCP29110 | Zanubrutinib | 1691249-45-2 |
Zanubrutinib is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.
|
![]() |
BCP29646 | Vecabrutinib | 1510829-06-7 |
Vecabrutinib, also known as SNS-062; FP-182, BSK-4841 and BIIB-062; is a potent, noncovalent, reversible BTK inhibitor that inhibits signaling through the BCR pathway.
|
